Managing pediatric atopic dermatitis

被引:47
作者
Raimer, SS [1 ]
机构
[1] Univ Texas, Med Branch, Dept Dermatol & Pediat, Galveston, TX 77550 USA
关键词
D O I
10.1177/000992280003900101
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Although atopic dermatitis is a very common inflammatory skin condition in children and results in many pediatric healthcare visits, its exact cause is unknown. No single laboratory test can reliably diagnose atopic dermatitis, but a relatively simple set of diagnostic criteria was recently validated for use by practicing physicians. Because existing remedies for atopic dermatitis do not cure the disorder, a program of disease control and management should be pursued. Patients and their caregivers should be advised that current therapies are primarily preventive and palliative. However, a comprehensive plan that includes routine general skin care, medical management of symptoms, identification and avoidance of aggravating factors (including psychological factors), and attention to quality-of-life issues can reduce the occurrence of skin flares. Successful treatment of acute flare-ups can be achieved with appropriate use of topical corticosteroids, but occasionally children afflicted with severe atopic dermatitis require more intensive therapies (e.g., ultraviolet light exposure, systemic corticosteroids, and cyclosporine) that need close physician monitoring. Physicians must remain mindful of the psychological and quality-of-life burdens imposed on children with atopic dermatitis and their families and tailor treatments to the needs of each individual patient.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 69 条
[1]   Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children [J].
Alaiti, S ;
Kang, SW ;
Fiedler, VC ;
Ellis, CN ;
Spurlin, DV ;
Fader, D ;
Ulyanov, G ;
Gadgil, SD ;
Tanase, A ;
Lawrence, I ;
Scotellaro, P ;
Raye, K ;
Bekersky, I .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (01) :69-76
[2]   Development and validation of a quality of life instrument for cutaneous diseases [J].
Anderson, RT ;
Rajagopalan, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (01) :41-50
[3]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[4]   Cyclosporine in severe childhood atopic dermatitis: A multicenter study [J].
BerthJones, J ;
Finlay, AY ;
Zaki, I ;
Tan, B ;
Goodyear, H ;
LewisJones, S ;
Cork, MJ ;
Bleehen, SS ;
Salek, MS ;
Allen, BR ;
Friedmann, P ;
Harper, J ;
Camp, RDR ;
Smith, S ;
GrahamBrown, RAC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) :1016-1021
[5]   FAILURE OF TERFENADINE IN RELIEVING THE PRURITUS OF ATOPIC-DERMATITIS [J].
BERTHJONES, J ;
GRAHAMBROWN, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (05) :635-637
[6]   FLUTICASONE PROPIONATE 0.05-PERCENT CREAM IN THE TREATMENT OF ATOPIC ECZEMA - A MULTICENTER STUDY COMPARING ONCE-DAILY TREATMENT AND ONCE-DAILY VEHICLE CREAM APPLICATION VERSUS TWICE-DAILY TREATMENT [J].
BLEEHEN, SS ;
CHU, AC ;
HAMANN, I ;
HOLDEN, C ;
HUNTER, JAA ;
MARKS, R .
BRITISH JOURNAL OF DERMATOLOGY, 1995, 133 (04) :592-597
[7]   A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children [J].
Boguniewicz, M ;
Fiedler, VC ;
Raimer, S ;
Lawrence, ID ;
Leung, DYM ;
Hanifin, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :637-644
[8]  
BONIFAZI E, 1989, ACTA DERM-VENEREOL, V144, P20
[9]   INCREASING INCIDENCE OF ECZEMA HERPETICUM - ANALYSIS OF 75 CASES [J].
BORK, K ;
BRAUNINGER, W .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (06) :1024-1029
[10]  
BROBERG A, 1992, ACTA DERM-VENEREOL, V72, P187